BridgeMD
New treatment option for Prediabetes
Official title Personalized Meal Timing and Walking Based on Glucose Patterns in Adults With Prediabetes
ClinicalTrials.gov ID: NCT07618663
What this study is testing
- What it's testing
- This study will test whether glucose sensor data can be used to identify the time of day when adults with prediabetes are most likely to have high blood sugar after meals. Participants will first wear a continuous glucose monitor and wrist activity monitor and record meal times for 10 days.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 30 to 70
You may be able to join if
- Age 30 to 70 years
- Prediabetes, defined as either:
- HbA1c 5.7% to 6.4% within 3 months of screening, or
- Fasting plasma glucose 100 to 125 mg/dL on two separate occasions
- Body mass index 23 to 40 kg/m²
You likely can't join if
- Current or prior diagnosis of type 1 diabetes or type 2 diabetes
- Use of glucose-lowering medication within the past 3 months
- Use of systemic corticosteroid medication within the past 3 months
- Use of prescription weight-loss medication within the past 3 months
- Current shift work
- Transmeridian travel across more than 2 time zones within 4 weeks before enrollment
See the full eligibility criteria
- Age 30 to 70 years
- Prediabetes, defined as either:
- HbA1c 5.7% to 6.4% within 3 months of screening, or
- Fasting plasma glucose 100 to 125 mg/dL on two separate occasions
- Body mass index 23 to 40 kg/m²
- Owns a smartphone compatible with study applications
- Willing to wear a continuous glucose monitor and wrist activity monitor during the study period
- Willing to record meals using timestamped meal-photo logging
- Able to provide written informed consent
- Current or prior diagnosis of type 1 diabetes or type 2 diabetes
- Use of glucose-lowering medication within the past 3 months
- Use of systemic corticosteroid medication within the past 3 months
- Use of prescription weight-loss medication within the past 3 months
- Current shift work
- Transmeridian travel across more than 2 time zones within 4 weeks before enrollment
- Known untreated or unstable sleep disorder, including obstructive sleep apnea, narcolepsy, or insomnia disorder
- Pregnancy, planned pregnancy, or breastfeeding
- Gastrointestinal disease or surgery likely to affect nutrient absorption
- Current participation in a structured dietary or exercise intervention program
- Estimated glomerular filtration rate less than 60 mL/min/1.73 m²
- Inability or unwillingness to comply with continuous glucose monitoring, wrist actigraphy, meal logging, or study visits
The study team makes the final eligibility decision.
Where it's taking place
- Lahore, Shaikhupura, Pakistan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 30 years to 70 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Lahore, Shaikhupura, Pakistan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.